Michael Fu

715 total citations
28 papers, 552 citations indexed

About

Michael Fu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Fu has authored 28 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 15 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Fu's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Viral Infections and Immunology Research (12 papers) and Receptor Mechanisms and Signaling (12 papers). Michael Fu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Viral Infections and Immunology Research (12 papers) and Receptor Mechanisms and Signaling (12 papers). Michael Fu collaborates with scholars based in Sweden, Japan and China. Michael Fu's co-authors include Johan Hoebeke, Shinobu Matsui, Shogo Katsuda, Takayuki Kurihara, Kohei Teraoka, Noboru Takekoshi, Nobuo Yamaguchi, Åke Hjalmarson, Eiji Murakami and Åke Hjalmarson and has published in prestigious journals such as European Respiratory Journal, European Journal of Pharmacology and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Michael Fu

27 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Fu Sweden 13 391 259 191 63 42 28 552
C Limas United States 10 282 0.7× 221 0.9× 92 0.5× 58 0.9× 30 0.7× 12 481
Kohei Teraoka Japan 10 238 0.6× 155 0.6× 134 0.7× 37 0.6× 27 0.6× 17 353
Lars R. Herda Germany 11 253 0.6× 152 0.6× 51 0.3× 49 0.8× 25 0.6× 20 407
Moritz Hundertmark United Kingdom 8 243 0.6× 110 0.4× 74 0.4× 23 0.4× 23 0.5× 19 404
M. Neuß Germany 11 417 1.1× 177 0.7× 219 1.1× 8 0.1× 24 0.6× 22 647
Weixing Hu China 12 69 0.2× 138 0.5× 57 0.3× 25 0.4× 90 2.1× 18 404
Jiqiang He China 10 138 0.4× 83 0.3× 70 0.4× 15 0.2× 21 0.5× 38 309
Katharine A. Kott Australia 11 78 0.2× 120 0.5× 35 0.2× 56 0.9× 24 0.6× 23 321
Daniëlle Hof Switzerland 10 77 0.2× 133 0.5× 67 0.4× 78 1.2× 40 1.0× 20 322
James A. Richardson United States 3 143 0.4× 251 1.0× 48 0.3× 57 0.9× 40 1.0× 5 509

Countries citing papers authored by Michael Fu

Since Specialization
Citations

This map shows the geographic impact of Michael Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fu more than expected).

Fields of papers citing papers by Michael Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fu. The network helps show where Michael Fu may publish in the future.

Co-authorship network of co-authors of Michael Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fu. A scholar is included among the top collaborators of Michael Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fu. Michael Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaojing, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, & Michael Fu. (2024). Incident Heart Failure: Comparing Management and Outcome in Primary and Hospital Settings in Western Sweden 2008–2017. ESC Heart Failure. 12(2). 832–838. 1 indexed citations
2.
Zhang, Zhong‐Yin, et al.. (2024). Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis. International Journal of Cardiology. 402. 131813–131813. 7 indexed citations
3.
Ljungman, Charlotta, Entela Bollano, Araz Rawshani, et al.. (2023). Differences in phenotypes, symptoms, and survival in patients with cardiomyopathy—a prospective observational study from the Sahlgrenska CardioMyoPathy Centre. Frontiers in Cardiovascular Medicine. 10. 1160089–1160089. 1 indexed citations
4.
Rosengren, Annika, et al.. (2022). Sex-related differences among young adults with heart failure in Sweden. International Journal of Cardiology. 362. 97–103. 2 indexed citations
5.
Zhang, Biqi, Lihong Qiu, Michael Fu, & Shen‐Jiang Hu. (2012). Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction. European Journal of Pharmacology. 692(1-3). 61–68. 7 indexed citations
6.
Deubner, Nikolas, Dominik Berliner, Angela Schlipp, et al.. (2010). Cardiac β1-Adrenoceptor Autoantibodies in Human Heart Disease: Rationale and Design of the E tiology, Ti tre- C ourse, and S urvival (ETiCS) Study. European Journal of Heart Failure. 12(7). 753–762. 45 indexed citations
7.
Fu, Michael. (2008). Autoimmunity and idiopathic dilated cardiomyopathy: Where we stand?. Autoimmunity. 41(6). 415–418. 5 indexed citations
8.
Matsui, Shinobu, et al.. (2008). Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats. Journal of Molecular and Cellular Cardiology. 44(6). 1023–1031. 12 indexed citations
9.
Tong, M.K.H., Christopher Wai Kei Lam, Tony W.L. Mak, et al.. (2006). Very long-chain acyl-CoA dehydrogenase deficiency presenting as acute hypercapnic respiratory failure. European Respiratory Journal. 28(2). 447–450. 15 indexed citations
10.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2005). Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID) mice induces cardiomyopathic changes. Autoimmunity. 39(2). 121–128. 13 indexed citations
11.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2003). Transfer of Rabbit Autoimmune Cardiomyopathy into Severe Combined Immunodeficiency Mice. Journal of Cardiovascular Pharmacology. 42. S99–S103. 21 indexed citations
12.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2001). Beneficial Effect of Muscarinic-2 Antagonist on Dilated Cardiomyopathy Induced by Autoimmune Mechanism against Muscarinic-2 Receptor. Journal of Cardiovascular Pharmacology. 38. S43–S49. 11 indexed citations
13.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (2000). Beneficial Effect of Angiotensin-Converting Enzyme Inhibitor on Dilated Cardiomyopathy Induced by Autoimmune Mechanism Against β1-Adrenoceptor. Journal of Cardiovascular Pharmacology. 36. S43–S48. 1 indexed citations
14.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (1999). Active immunization of combined β1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits. Journal of Cardiac Failure. 5(3). 246–254. 32 indexed citations
15.
Fu, Michael, et al.. (1998). Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with anti-peptide antibodies showing a positive chronotropic effect.. PubMed. 6(2). 99–111. 33 indexed citations
16.
Matsui, Shinobu, Michael Fu, Shogo Katsuda, et al.. (1997). Peptides Derived from Cardiovascular G-protein-coupled Receptors Induce Morphological Cardiomyopathic Changes in Immunized Rabbits. Journal of Molecular and Cellular Cardiology. 29(2). 641–655. 138 indexed citations
17.
18.
19.
Schulze, Wolfgang, et al.. (1995). Immunocytochemical studies of the Gi Protein mediated muscarinic receptor-adenylyl cyclase system. Molecular and Cellular Biochemistry. 147(1-2). 161–168. 6 indexed citations
20.
Fu, Michael, et al.. (1994). Immunocytochemical localization of M2 muscarinic receptors in rat ventricles with anti-peptide antibodies.. Journal of Histochemistry & Cytochemistry. 42(3). 337–343. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Limas Breakdown of academic impact, for papers by Kohei Teraoka Breakdown of academic impact, for papers by Lars R. Herda Breakdown of academic impact, for papers by Moritz Hundertmark Breakdown of academic impact, for papers by M. Neuß Breakdown of academic impact, for papers by Weixing Hu Breakdown of academic impact, for papers by Jiqiang He Breakdown of academic impact, for papers by Katharine A. Kott Breakdown of academic impact, for papers by Daniëlle Hof Breakdown of academic impact, for papers by James A. Richardson
Rankless by CCL
2026